A recent study showed potential improvement in motor ability for Parkinson’s patients treated with the diabetes medicine lixisenatide, though caution is advised. The study is small and short-term, with uncertainties about dosage and long-term impact. Larger trials are needed before recommending this strategy. Newer drugs like Ozempic and Wegovy offer alternatives, pending further research.







